Activity Overview
Health-system pharmacists are an integral part of the interdisciplinary team that is critical in the management of pain. Increasingly involved in many aspects of patient care, these pharmacists are uniquely positioned to contribute substantially to pain management throughout the continuum of care, from acute treatment through chronic pain management. This educational activity will focus on the critical dilemmas that are woven within treatment decisions throughout the pain continuum. Health-system pharmacists will be educated on: (1) how to distinguish acute from chronic pain; (2) how to choose optimal treatment strategies; and (3) when to safely and effectively utilize opiates in their patients’ pain management regimes. Through dynamic presentations and interactive cases, attendees will walk away with the skills to apply this current information to their clinical practice.

Agenda

11:30 - 11:45 AM Conference Goals/Pre-Test
J. Richard Brown, PharmD, FASHP
11:45 - 12:00 PM The Pain Continuum: From Acute Treatment to Chronic Management
J. Richard Brown, PharmD, FASHP
12:00 - 12:40 PM Treatment of Pain: Current Concepts
Robert L. Barkin, PharmD, MBA, FCP, DAAPM
12:40 - 1:15 PM Managing Pain with Opiates: Strategies for Health-System Pharmacists
Bruce R. Canaday, PharmD, FASHP, FAPhA
1:15 - 1:30 PM Closing Comments/Post-Test and Q&A

Goal
To provide health-system pharmacists attending the 44th ASHP Midyear Clinical Meeting and Exhibition with an enhanced understanding of the etiology and current pharmacologic treatment of acute and chronic pain, and to impart that knowledge to the interdisciplinary team for optimal patient outcomes.

Intended Audience
This activity is designed for pharmacists attending the 44th ASHP Midyear Clinical Meeting and Exhibition. No prerequisites required.

Learning Objectives
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. Upon the conclusion of this activity, the participant should be able to:

  • EXPLAIN the clinical, psychological, and economic impact of acute pain, with particular attention to special populations (ie, elderly).
  • REVIEW current and emerging pharmacologic treatments for acute pain, including efficacy, mechanisms of action, and adverse effects including addiction.
  • IDENTIFY the role of the pharmacist in the interdisciplinary team for optimal management of acute pain.
  • RECOGNIZE the economic impact of inadequate pain management in the health-system setting and formulate strategies to optimize patient and health-system outcomes.

Accreditation Statement
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education to provide continuing education for pharmacists.

Credit Designation Statement
This application-based activity is sponsored by the University of Tennessee College of Pharmacy who is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this application-based educational activity will provide 2.0 contact hours credit (0.2 CEUs). A statement of CPE credit will be mailed within 4 weeks following successful completion of the educational activity. Successful completion includes attending the session, signing the attendance sheet, and completion of the educational activity evaluation form. ACPE Program #064-000-09-207-L01-P.

Faculty
J. Richard Brown, PharmD, FASHP (Chair)
Professor, Clinical Pharmacy
University of Tennessee
Memphis, Tennessee

Robert L. Barkin, PharmD, MBA, FCP, DAAPM
Professor, Rush Medical College
Faculty of Anesthesiology, Family Medicine, and Pharmacology
Rush University Medical Center
Clinical Pharmacologist, Northshore University Health System—Skokie, Evanston Hospitals, Pain Centers, and   The Department of Anesthesiology
Chicago, Illinois

Bruce R. Canaday, PharmD, FASHP, FAPhA
Clinical Professor and Vice-Chair
Division of Pharmacy Practice and Experiential Education
University of North Carolina Eshelman School of Pharmacy
Chapel Hill, North Carolina

Policy on Faculty and Provider Disclosure
It is the policy of The University of Tennessee College of Pharmacy that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during the presentation(s). Detailed disclosures will be made in the course handout materials.

Americans with Disabilities Act (ADA)
The University of Tennessee College of Pharmacy fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Grievance Policy
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an educational activity sponsored or cosponsored by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.

Fee Information
There is no fee for this educational activity.

Supported by an educational grant from PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
 
     
Home | Contact Us | View Account | Need Help? | Subscription